Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Updated Pfizer-BioNTech’s COVID-19 vaccine approved by Health Canada
Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine
Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY® COVID-19 vaccine for ages 6 months and older. The updated COMIRNATY® vaccine targets the Omicron KP.
Pfizer/BioNTech Covid-19 Vaccine Adapted for KP.2 Strain Gets Canada Approval
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More.
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA)
Pfizer's updated COVID-19 vaccine approved, Health Canada says
Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada said on Tuesday.
Health Canada approves Pfizer-BioNTech's updated COVID-19 vaccine
BioNTech's updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine formulations that protect against the most recently circulating variants of the virus.
Pfizer’s updated COVID-19 vaccine approved by Health Canada
The mRNA vaccine, called Comirnaty, targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 Omicron subvariant.
Time on MSN
1d
Is the Novavax COVID-19 Vaccine Better?
While the new mRNA vaccines from Moderna and
Pfizer
-
BioNTech
have dominated the COVID-19 vaccine story, there is another ...
2d
2 Beaten-Down Stocks to Buy and Hold for a Decade
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
1d
Jefferies Sticks to Its Buy Rating for Pfizer (PFE)
Jefferies analyst Akash Tewari maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $35.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Food packaging cancer risk
Woman dies in 'suicide pod’
Penn suspends law professor
US to waive visas for Qatar
Pres candidates' security bill
InfoWars to be auctioned off
Recalls 41K+ motorcycles
Executed by lethal injection
Campaign office damaged
Partners with Google
Union gets more voting time
Briefed on Iranian threats
$375M military aid to UKR
Texas AG appeal denied
Calls strike against 'LoL’
X account hacked
Dali owner, operator sued
Rioter mistakenly released
Severe obesity on the rise
‘Trump Train’ jury verdict
ISR: Hezbollah leader killed
Retiring after 14 seasons
NYC schools boss retiring
NC sending absentee ballots
Johnny Cash statue unveiled
Pac-12 sues Mountain West
China conducts ICBM test
EEOC blocked on rules
PA county ballot ruling
Related topics
COVID-19
North Korea
Novavax
Comirnaty
Feedback